Post Profile

Bad Patents and the False Claims Act

by Dennis Crouch An interesting False Claims Act case has recently been unsealed. USA ex rel. Lower Drug Prices for Consumers (LDPFC) v. Allergan and Forest Labs., Case No. 16-cv-09 (E.D.Tex. 2016) (SEALED USA Complaint). The False Claims Act provides special incentives for whistleblowers to uncover fraud against the U.S. Government.  The Act authorizes the whistleblower to […]
read more


Related Posts

On Appeal, Abuse-Deterrent OxyContin Patents are Invalid

Industries / Law : Patent Law Blog (Patently-O)

By Dennis Crouch Purdue Pharma v. Epic Pharma (Fed. Cir. 2016)[1] In an important Hatch-Waxman related decision, the Federal Circuit has affirmed the lower court’s holding that Purdue Pharma’s abuse deterrent OxyContin patent claims...

false marking, not false advertising

Industries / Law : 43(B)log

Forest Group, Inc. v. Bon Tool Co., 2008 WL 2962206 (S.D. Tex.) Forest sued Bon Tool for patent infringement. Bon Tool counterclaimed for false marking under 35 U.S.C. § 292 and false advertising under the Lanham Act, along with inv...

Method Patent Claims

Industries / Law : Patent Law Blog (Patently-O)

by Dennis Crouch The Patent Act opens the door to patenting of “any new and useful process, machine, manufacture, or composition of matter.” In recent years, the patenting of processes in particular (or at least process claims) has ...

Personalized Medicine May be Patentable, but Not for Prometheus

Industries / Law : Patent Law Blog (Patently-O)

By Dennis Crouch Prometheus Labs v. Roxane Labs (Fed. Cir. 2015) In this case, the Federal Circuit has affirmed the district court’s holding that that Prometheus’ asserted patent claims are invalid as obvious. The district court had...

Four Opinions Defining “a Patient” and Is a Natural Phenomena an Act of God?

Industries / Law : Patent Law Blog (Patently-O)

By Dennis Crouch Braintree Labs v Novel Labs (Fed. Cir. 2014) I see this case as highlighting the most critical and problematic problem with our patent system – that patent claim scope is intentionally ambiguous and malleable. Consi...


Copyright © 2016 Regator, LLC